MedMira Cost Of Revenue from 2010 to 2024

MIR Stock  CAD 0.07  0.01  16.67%   
MedMira Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 113 K in 2024. During the period from 2010 to 2024, MedMira Cost Of Revenue regression line of quarterly data had mean square error of 586.4 B and geometric mean of  328,106. View All Fundamentals
 
Cost Of Revenue  
First Reported
2001-10-31
Previous Quarter
298.7 K
Current Value
276.7 K
Quarterly Volatility
269.8 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MedMira financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MedMira's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.5 K, Selling General Administrative of 1.2 M or Selling And Marketing Expenses of 216.8 K, as well as many indicators such as Price To Sales Ratio of 85.38, Dividend Yield of 0.0 or Days Sales Outstanding of 1.2 K. MedMira financial statements analysis is a perfect complement when working with MedMira Valuation or Volatility modules.
  
This module can also supplement various MedMira Technical models . Check out the analysis of MedMira Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MedMira Stock Analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.